Lipella Pharmaceuticals Inc.

NASDAQ (USD): Lipella Pharmaceuticals Inc. (LIPO)

Last Price

4.22

Today's Change

+1.60 (61.06%)

Day's Change

4.07 - 7.31

Trading Volume

71,121,899

Overview

Market Cap

5 Million

Shares Outstanding

1 Million

Avg Volume

126,820

Avg Price (50 Days)

2.89

Avg Price (200 Days)

3.85

PE Ratio

-0.97

EPS

-4.29

Earnings Announcement

26-Feb-2025

Previous Close

2.62

Open

6.65

Day's Range

4.07 - 7.31

Year Range

2.21 - 12.0

Trading Volume

71,139,568

Price Change Highlight

1 Day Change

59.55%

5 Day Change

55.40%

1 Month Change

17.10%

3 Month Change

64.58%

6 Month Change

-13.99%

Ytd Change

31.46%

1 Year Change

-45.57%

3 Year Change

-27.30%

5 Year Change

-27.30%

10 Year Change

-27.30%

Max Change

-27.30%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. The company was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment